Sector Chart Biosergen AB

Equities

BIOSGN

SE0016013460

Delayed Nasdaq Stockholm 03:38:31 2024-05-14 am EDT 5-day change 1st Jan Change
0.306 SEK +13.33% Intraday chart for Biosergen AB -10.53% -65.23%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
3.54M - - - - -
111B
105B
21.93B -
22.34B -
18.59B
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW